Hong Kong Life Sciences and Technologies Group Ltd operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hong Kong Life Sciences and Technologies Group Ltd with three other
drug stores in Asia:
Dhruv Wellness Ltd
sales of 1.04 billion Indian Rupees [US$14.11 million]
Gillette Pakistan Ltd
(1.83 billion Pakistan Rupees [US$13.92 million]
Hin Sang Group (International) Holding Co Ltd
(188.55 million Hong Kong Dollars [US$24.06 million]
of which 96%
was Product Development Segment).
Hong Kong Life Sciences and Technologies Group Ltd reported sales of HK$140.21 million (US$17.89 million)
March of 2018.
decrease of 8.7%
versus 2017, when the company's sales were HK$153.57 million.
Contributing to the drop in overall sales was the 21.8% decline
in Money Lending Business, from HK$27.83 million to HK$21.77 million.
There were also decreases in sales in
Trading Business (down 6.2% to HK$114.28 million)
However, these declines were partially offset by the increase in sales of
Anti-Aging and Stem Cell Technology Busine (up 7.5% to HK$4.16 million)